Top US Epidemiology Expert Infected With the CCP Virus One Month After He Helped China Defend the Origin of the Virus

Top US Epidemiology Expert Infected With the CCP Virus One Month After He Helped China Defend the Origin of the Virus
Scanning electron microscope image shows the CCP virus (round blue objects), the virus that causes COVID-19, emerging from the surface of cells cultured in the lab. (NIAID-RML)

Walter Ian Lipkin, professor of epidemiology at Columbia University, known as a “virus hunter,” revealed in an interview on Fox Business Network that he has tested positive for the CCP (Chinese Communist Party) virus on March 24.

Lipkin is the director of Columbia University’s Center for Infection and Immunity, and has earned the reputation of a “virus hunter” for his efficiency and innovative methods of identifying new viruses. In the past 30 years, he has been involved in the epidemic control of almost all major contagions in the world, including West Nile virus and SARS. In addition, he has discovered and identified more than 800 viruses causing human, wildlife or domestic animal diseases.

Lipkin’s friendship with the Chinese communist regime probably started in 2003 when he was invited to visit Beijing during the SARS outbreak. Working closely with a team in Beijing headed by then Vice President of the Chinese Academy of Sciences Chen Zhu, Lipkin and Chinese medical scientists developed a strategy to combat SARS. He also gifted 10,000 SARS test kits to China.

Subsequently, Lipkin assisted China in setting up disease research institutions such as Institut Pasteur of Shanghai (IPS) and Guangzhou Institute of Biomedicine and Health. In May 2013, he went to Beijing again and signed a contract with the Virology Institute of China’s Center for Disease Control, to build a collaboration lab for pathogen research. All investment for this project came from the Chinese authorities.

Chinese state media often praise Lipkin for having made “great contribution” to China in the past ten years. In 2015, he was among one of the seven foreign recipients of China’s International Science and Technology Cooperation Award.

Has Lipkin procured any personal gains from the over ten years of “contribution?” Although there is no clear evidence on that, his statement after the CCP virus outbreak is telling the world that he certainly has an intimate tie with the CCP.

Lipkin was in China from Jan. 28 to Feb. 4, and met with high-ranking officials as well as top medical experts, including China’s chief coronavirus consultant Zhong Nanshan. Nonetheless, he did not go to Wuhan, the epicenter of the CCP virus.

On Feb. 24, Lipkin accepted an interview by Yang Lan, a famous TV hostess in China, and made a key statement in support of the Chinese authorities with regard to the origin of the CCP virus.

“What my colleagues and I think happened was that this virus was existing in a bat, probably came into contact with an animal, perhaps in a wild animal market, perhaps an infected human,” he said.

“We don’t think there’s any evidence that this virus was created in the Wuhan Institute of Virology or released accidentally. We think it emerged in nature. It’s a natural problem. And we need to address it as a naturally occurring virus.”

Dr. Lyons-Weiler, the founder and CEO of the Institute for Pure and Applied Knowledge (IPAK), published an article on Jan. 31 stating that medical research found evidence that might suggest the CCP virus could come out from a laboratory-induced event.

He said that “the available evidence most strongly supports that the 2019-NCoV virus is a vaccine strain of coronavirus either accidentally released from a laboratory accident, perhaps a laboratory researcher becoming infected with the virus while conducting animal experiments, or the Chinese were performing clinical studies of a coronavirus vaccine in humans.”

During the interview with Yang on Feb. 24, Lipkin did not provide any scientific evidence or argument to refute Lyon-Weiler’s statement.

Special Coverage: For our latest coverage of the CCP Virus Outbreak, visit our new section and sign up for our daily newsletter.